Samit Hirawat
Förmögenhet: 2 M $ per 2026-10-31
Förmögenhet: 2 M $ per 2026-10-31
Samit Hirawat is currently an Independent Director at Pacira Biosciences, Inc. and Iambic Therapeutics, Inc., and an Operating Partner at Jeito Capital, all starting in 2026.
Formerly, Dr. Hirawat was Chief Medical Officer-Global Drug Development at Bristol Myers Squibb Co. from 2019 to 2025 and Head- Global Oncology Development at Novartis AG from 2017 to 2019.
Education includes an undergraduate degree from SMS Medical College & Hospital.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-12 | 31 925 ( 0 % ) | 2 M $ | 2026-10-31 | |
PACIRA BIOSCIENCES, INC. 0,02 % | 2026-06-10 | 6 405 ( 0,02 % ) | 233 078 $ | 2026-10-31 |
| Företag | Position | Start |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2026-01-27 |
| IAMBIC THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2026-08-01 |
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Teknisk/Vetenskaplig/F&U Direktör | 2025-08-01 |
| NOVARTIS AG | Företagsledare/Principal | 2019-06-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
Entos, Inc. BiotechnologyHealth Technology Operates as a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån